Logistics for medical food products
The expansion is needed because of the growing demand for Abbott’s medical food products. The firm has also revealed ambitious plans to expand its Abbot Labs operation in Zwolle where it produces baby food and intravenous nutrition products. The expansion involves an investment in the tens of millions of euros and will create around 100 new jobs, taking the workforce at this location to around 550. The Zwolle facility produces more than 180 nutritional products that are distributed throughout the rest of Europe and further afield.
In addition to a new production line for liquid medical nutrition, the expansion will encompass a new packaging line and energy supply. The new production line is expected to be up and running by the spring of 2021 and recruitment has already commenced. The products from the Zwolle factory are distributed from Breda to countries within and outside of Europe.
Abbott promotes health & nutrition in the Netherlands
Since it established operations in the Netherlands life sciences and health sector some 60 years ago, Abbott has continued to grow. It has state-of-the-art locations in Alkmaar, Breda, Heerlen, Hoofddorp, Olst, Weesp and Zwolle. Abbott currently employs around 1,800 people across nine locations in the Netherlands.
Abbott is focused on developing sustainable solutions for unique health challenges. It is specialized in the production of science-based food products, diagnostic equipment and medical devices. This includes breakthrough technologies to minimize routine needles for diabetic patients or facilitating a revolutionary treatment of cardiovascular diseases in the Netherlands.
Abbott is a leading global medical company that aims to help people get more out of life at all stages of life. It offers life-changing technologies and leading products in the field of diagnostics, medical equipment, food and generic medicines. Headquartered in the United States, Abbott employs 107,000 people in more than 160 countries.
Source: Abbott Netherlands